The Gavi Matching Fund is a public-private funding mechanism designed to incentivise private sector investments in immunisation.
INCENTIVISING INVESTMENT
Since its launch in 2011, the Matching Fund has played an important role in encouraging business to invest in immunisation. By matching private sector contributions in cash or in kind, this mechanism helps Gavi secure the resources and expertise required to modernise vaccine delivery systems. The Matching Fund also provides long-term funding visibility that gives Gavi-supported countries the confidence to introduce new vaccines.
HOW THE MATCHING FUND IS FINANCED
The Gavi Matching Fund was established in partnership with the Bill & Melinda Gates Foundation (BMGF) and the United Kingdom’s Department for International Development. Together, they pledged the equivalent of US$ 111 million1 for the 2011-2015 period (US$ 50 million and US$ 61 million, respectively). These commitments have been used to match contributions from corporations and their employees, foundations and other organisations, resulting in a total of US$ 210 million2 pledged to Gavi for the 2011-2015 period.
In 2016, the BMGF and the Government of the Netherlands committed US$ 75 million and EUR 10 million respectively to the Gavi Matching Fund. Over the 2016–2020 period, these funds will be made available to match private sector investments in Gavi- supported programmes.
1 Figure as of June 30, 2016
2 The remaining portion of the GMF has been matched against cash and in-kind contributions expected during the 2016-2020 strategic period.